82 related articles for article (PubMed ID: 18942148)
1. Clinical presentation of patients with late target lesion revascularization.
Kaneda H
Catheter Cardiovasc Interv; 2008 Nov; 72(5):749. PubMed ID: 18942148
[No Abstract] [Full Text] [Related]
2. Long-term follow-up of the First In Man experience with everolimus-eluting stents.
Kimmelstiel C
Catheter Cardiovasc Interv; 2010 Jun; 75(7):1004-5. PubMed ID: 20517960
[No Abstract] [Full Text] [Related]
3. Treatment of drug-eluting stent restenosis: a sandwich may not be the best combo.
Belardi J
Catheter Cardiovasc Interv; 2008 Apr; 71(5):599. PubMed ID: 18360848
[No Abstract] [Full Text] [Related]
4. Stent fracture-unusual cause of DES restenosis.
Goyal BK
Catheter Cardiovasc Interv; 2007 Jun; 69(7):993-4. PubMed ID: 17525958
[No Abstract] [Full Text] [Related]
5. The long-term results of the "Endeavor" stent.
Kornovski R
Catheter Cardiovasc Interv; 2009 Dec; 74(7):996-9. PubMed ID: 19953512
[No Abstract] [Full Text] [Related]
6. Drug-eluting stent in saphenous vein graft lesions.
Kornowski R
Catheter Cardiovasc Interv; 2008 Jun; 71(7):894-5. PubMed ID: 18498140
[No Abstract] [Full Text] [Related]
7. Is there a preferable DES in diabetic patients? A critical appraisal of the evidence.
Byrne RA; Kastrati A
Catheter Cardiovasc Interv; 2008 Dec; 72(7):944-9. PubMed ID: 19021280
[TBL] [Abstract][Full Text] [Related]
8. If I've heard it once, I've heard it (not yet) a hundred times.
Butman SM
Catheter Cardiovasc Interv; 2011 Mar; 77(4):502. PubMed ID: 21351224
[No Abstract] [Full Text] [Related]
9. Incidence and predictors of clinically driven target lesion revascularization from bare-metal stents to drug-eluting stents.
Park SJ
Catheter Cardiovasc Interv; 2007 Aug; 70(2):184. PubMed ID: 17630660
[No Abstract] [Full Text] [Related]
10. Drug-eluting balloon: the comeback kid?
Waksman R; Pakala R
Circ Cardiovasc Interv; 2009 Aug; 2(4):352-8. PubMed ID: 20031739
[No Abstract] [Full Text] [Related]
11. Paclitaxel-eluting balloon: from bench to bed.
De Labriolle A; Pakala R; Bonello L; Lemesle G; Scheinowitz M; Waksman R
Catheter Cardiovasc Interv; 2009 Apr; 73(5):643-52. PubMed ID: 19309715
[TBL] [Abstract][Full Text] [Related]
12. "Neither horseshoes nor hand grenades"--does close count in percutaneous coronary revascularization?
Bailey SR
Catheter Cardiovasc Interv; 2008 Oct; 72(4):457-8. PubMed ID: 18819143
[No Abstract] [Full Text] [Related]
13. Inflation time and drug-eluting stent: the longer, the better..
Bertrand OF
Catheter Cardiovasc Interv; 2009 Feb; 73(2):212-3. PubMed ID: 19156881
[No Abstract] [Full Text] [Related]
14. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
[TBL] [Abstract][Full Text] [Related]
15. Comparative healing response after sirolimus- and paclitaxel-eluting stent implantation in a pig model of restenosis.
Silva GV; Fernandes MR; Madonna R; Clubb F; Oliveira E; Jimenez-Quevedo P; Branco R; Lopez J; Angeli FS; Sanz-Ruiz R; Vaughn WK; Zheng Y; Baimbridge F; Canales J; Cardoso CO; Assad JA; Falotico R; Perin EC
Catheter Cardiovasc Interv; 2009 May; 73(6):801-8. PubMed ID: 19309735
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry.
Tamburino C; Barbagallo R; Capodanno D; di Matteo S; Colombo GL; Recchia M; Ciriminna S;
J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):322-9. PubMed ID: 19430343
[TBL] [Abstract][Full Text] [Related]
17. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
Lee JY; Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Park SW; Park SJ
J Am Coll Cardiol; 2009 Aug; 54(9):853-9. PubMed ID: 19695467
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous revascularization of the "unprotected" left main during acute myocardial infarction: "Dare to struggle! Dare to win!".
Morrison DA
Catheter Cardiovasc Interv; 2009 Jan; 73(1):22-4. PubMed ID: 19089931
[No Abstract] [Full Text] [Related]
19. SES for AMI: moving in the right direction.
Vetrovec GW
Catheter Cardiovasc Interv; 2009 Aug; 74(2):333-4. PubMed ID: 19642181
[No Abstract] [Full Text] [Related]
20. "Anti-healing" versus "pro-healing".
Seth DA
Catheter Cardiovasc Interv; 2008 Apr; 71(5):605-6. PubMed ID: 18360850
[No Abstract] [Full Text] [Related]
[Next] [New Search]
